2022 ASCO Annual Meeting

New Research From the 2022 ASCO Annual Meeting 

The ASCO Annual Meeting is just around the corner, and for the first time since 2019, thousands of oncology professionals will be gathering in Chicago—joined virtually by thousands more—to learn about new and important developments in cancer research, treatment, and patient care. I’m excited to be attending in person again to reconnect with global experts in cancer care.

At Cancer.Net, we know that having trustworthy, patient-focused summaries of complex research is important to our readers. That's why I'm thrilled to share these summaries of new research in health equity and cancer disparities. It's such a critical field of study, and the work of these researchers can help ensure that all people can get the cancer care they need and deserve.

Today is just the beginning of our coverage of the ASCO Annual Meeting. We will be publishing research summaries on the Cancer.Net Blog every day of the meeting, from June 3 to June 7, so remember to follow us on Twitter and Facebook and to check the Cancer.Net Blog daily during the meeting.

—Dr. Jyoti D. Patel, Cancer.Net Editor in Chief

Read the latest research:

• Increased spending by states in social services is associated with improved 5-year overall survival for Black people with cancer (also in Spanish)

• Nearly half of Black people with metastatic breast cancer are not informed about clinical trials (also in Spanish)

• Telemedicine use for cancer care increased during the COVID-19 pandemic but varied by race, income, and other factors (also in Spanish)

• Race, ethnicity, and poverty are associated with lower overall survival in children with high-risk neuroblastoma (also in Spanish)

• Adding nimotuzumab to gemcitabine helps some people with advanced pancreatic cancer live longer (also in Spanish)

• Adding ibrutinib to treatment improves progression-free survival by 50% for older adults with mantle cell lymphoma (also in Spanish)

• Sacituzumab govitecan delays cancer growth for some people with advanced hormone receptor-positive, HER2-negative breast cancer (also in Spanish)

• Liquid biopsy may reduce the need for chemotherapy after surgery in some people with stage II colon cancer (also in Spanish)

• Trastuzumab deruxtecan doubles progression-free survival in metastatic breast cancer with low HER2 expression levels (also in Spanish)

• Adding panitumumab to chemotherapy helps people with RAS wild-type metastatic colorectal cancer live longer (also in Spanish)

• High-dose ifosfamide helps people with recurrent and refractory Ewing sarcoma live longer (also in Spanish)

• Stem cell transplant improves progression-free survival for younger people with newly diagnosed multiple myeloma (also in Spanish)

• Targeted therapy combination helps shrink tumors in children with low-grade glioma with a BRAF V600 mutation (also in Spanish)

• Biomarker testing may help people 55+ with low-grade luminal A breast cancer avoid radiation therapy after surgery (also in Spanish)

From the Editor in Chief

Cancer.Net's 20th Anniversary: Celebrating Our Mission of Providing Trustworthy Cancer Information

In this month's "From the Editor in Chief" column, Dr. Jyoti Patel reflects on the 20th anniversary of Cancer.Net and discusses the evolution of ASCO's patient information website over 20 years, the information Cancer.Net provides today, and why this information is more important than ever before.

More News From the Cancer.Net Team

Register Now for a Free GU Cancers Research Round Up Webinar

On Wednesday, June 15 at 2:00 PM (ET), experts from the Cancer.Net Editorial Board will discuss new research in prostate, testicular, bladder, and kidney cancers presented at this year's ASCO Annual Meeting and Genitourinary Cancers Symposium. Get answers to your questions and learn what this research means for people with cancer. Look for more Research Round Up webinars and podcasts later this summer.

Patient Advocate Programs at the ASCO Annual Meeting

The 2022 ASCO Annual Meeting offers opportunities to engage and stay up to date on new clinical cancer advances in every area of cancer research, gain real-time insights from world-renown faculty, and connect with one of the largest, most diverse audiences in global oncology—in person or online. Learn about ASCO's Patient Advocate Programs at the ASCO Annual Meeting.

Follow #ASCO22 for ASCO Annual Meeting News

The ASCO Annual Meeting will take place June 3-7. Get the latest research news by following the hashtag #ASCO22 on social media. And, don't forget to follow and like @CancerDotNet on Twitter and Facebook to get more patient-centered coverage of cancer research highlights.